Abstract
Optical properties and fluorescence decay dynamics of a photoactive indole based antibacterial chromophore system, 2,3-distyrylindole (23DSI), were investigated using various spectroscopic characterization techniques. Experimental studies were done by utilizing steady-state UV-vis spectroscopy, steady-state fluorescence spectroscopy, time-resolved fluorescence upconversion spectroscopy, and time-correlated single-photon counting spectroscopy. Our studies show that the 23DSI molecule has a multiphoton absorption property as indicated by two- and three-photon absorption in the both the solution and the solid phases. The ultrafast time-resolved fluorescence upconversion studies show that this molecule undergoes a fast decay process with an average time constant of 34 ps, a single exponential decay, and an average fluorescence lifetime of 1 ns. The compound 23DSI did not show any signs of singlet oxygen production. The density functional theory (DFT) calculations showed that the 23DSI molecule has conjugated electron densities that are responsible for multiphoton absorption. The chlorine-substituted styryl groups, attached to the central indole ring facilitate the excellent electron delocalization within the molecule. This optimal electron delocalization, combined with the good electron conjugation in the 23DSI molecule is important for efficient multiphoton absorption and is in excellent agreement with experimental observations. Both the optical spectrum and emission spectrum using DFT calculations are also surprisingly well matched with the experimentally measured UV-vis spectrum and the emission spectrum, respectively. Combined experimental and theoretical studies suggest that excited electrons initially relax to the singlet state (S1) by internal conversion (IC) and subsequently relax back to their ground state by emitting absorbed energy as fluorescence emission. The outstanding multiphoton absorption capabilities of this 23DSI molecule support its potential application in both biological imaging and photodynamic inactivation (PDI).